. 2021 Jun 11;32(2):313–322. doi: 10.52312/jdrs.2021.72

Table 3. The histomorphometric findings measured at two and six weeks in the control, V5 (Vardenafil 5 mg) and V10 (Vardenafil 10 mg) groups.

	2nd	week	6^th week
	Cartilaginous callus area/total callus area	Total callus diameter/femoral diameter	Total callus diameter/femoral diameter
%	Mean±SE	Mean±SE	Mean±SE
Control group	47.47±4.67	43.85±4.08	17.85±4.45
V5 group	82.68±5.56**	56.55±6.70	6.39±1.55*
V10 group	90.90±4.08**	47.09±4.79	4.84±0.58*
p value	<0.0001	0.153	0.0088
All data were measured in μm; SE: Standard error; * p<0.01 and ** p<0.001 vs control group.